SAN DIEGO--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, today announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit.
Click here to read the full press release from Business Wire.
